On January 18, 2021 the Ministry of Health and Medical Industry of Turkmenistan announced the registration of the Russian Sputnik V vaccine against coronavirus developed by the Gamaleya Research Institute of Epidemiology and Microbiology with the support of the Russian Direct Investment Fund.
Thus, Turkmenistan became the first country in Central Asia to officially approve the use of the Sputnik V vaccine on its territory.
It was another step in the fight against infectious diseases and strengthening scientific and medical multilateral cooperation, to the development of which the Turkmen leader pays great attention, putting forward international initiatives in this area, maintaining active cooperation with specialized structures of the United Nations, including WHO.
Turkmenistan has the greatest respect for the experience of other states that have already created a solid base in the fight against the new threat and share valuable experience in overcoming the negative consequences of the pandemic.
Turkmenistan is also ready to share its successful developments in order to achieve the maximum level of efficiency of joint efforts with other countries and international organizations.